ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+22.28%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$507M
AUM Growth
+$507M
(+6.2%)
Cap. Flow
-$5.68M
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
74.82%
Holding
77
New
18
Increased
7
Reduced
8
Closed
10
Top Buys
| 1 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$12.4M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$9.73M |
| 3 |
Sarepta Therapeutics
SRPT
|
$7.93M |
| 4 |
Viking Therapeutics
VKTX
|
$7.12M |
| 5 |
OBSV
ObsEva SA Ordinary Shares
OBSV
|
$6.42M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$26M |
| 2 |
Ascendis Pharma
ASND
|
$15.5M |
| 3 |
Arrowhead Research
ARWR
|
$9.95M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$7.42M |
| 5 |
Tandem Diabetes Care
TNDM
|
$6.68M |
Sector Composition
| 1 | Healthcare | 75.18% |
| 2 | Communication Services | 0% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $112M | 20.01% | 4,750,000 -1,100,000 | -19% | -$26M |
|
2
Iovance Biotherapeutics
IOVA
$807M
| $51.5M | 9.17% | 4,025,000 -235,000 | -6% | -$3.01M |
|
3
Assembly Biosciences
ASMB
$190M
| $45.6M | 8.11% | 1,162,000 +47,000 | +4% | +$1.84M |
|
4
argenx
ARGX
$43.6B
| $37.6M | 6.69% | 453,233 +49,412 | +12% | +$4.09M |
|
|
KDMN
5
DELISTED
Kadmon Holdings, Inc.
KDMN
| $36.1M | 6.44% | 9,060,014 +3,110,014 | +52% | +$12.4M |
|
6
Veracyte
VCYT
$2.39B
| $24.8M | 4.42% | 2,660,210 -657,790 | -20% | -$6.14M |
|
|
CEMI
7
DELISTED
Chembio diagnostics, Inc.
CEMI
| $22.5M | 4.01% | 2,030,533 +23,866 | +1% | +$265K |
|
|
8
Ascendis Pharma
ASND
$11.8B
| $20.7M | 3.68% | 311,111 -232,889 | -43% | -$15.5M |
|
|
9
Arrowhead Research
ARWR
$3.05B
| $14M | 2.49% | 1,030,330 -731,876 | -42% | -$9.95M |
|
10
IRIDEX
IRIX
$22.8M
| $13.9M | 2.48% | 2,000,000 | – | – |
|
11
Indaptus Therapeutics
INDP
$7.19M
| $13M | 2.32% | 2,962,568 +238,285 | +9% | +$1.05M |
|
|
VRAY
12
DELISTED
ViewRay, Inc.
VRAY
| $10.3M | 1.84% | 1,495,000 -357,878 | -19% | -$2.48M |
|
|
CASM
13
DELISTED
CAS Medical Systems, Inc.
CASM
| $10.3M | 1.83% | 5,263,508 +46,510 | +0.9% | +$90.7K |
|
|
14
Madrigal Pharmaceuticals
MDGL
$9.76B
| $9.73M | 1.73% | +34,803 | New | +$9.73M |
|
15
Gyre Therapeutics
GYRE
$703M
| $9.69M | 1.72% | 830,000 -324,722 | -28% | -$3.79M |
|
|
16
Sarepta Therapeutics
SRPT
$1.78B
| $7.93M | 1.41% | +60,000 | New | +$7.93M |
|
|
17
Viking Therapeutics
VKTX
$3.04B
| $7.12M | 1.27% | +750,000 | New | +$7.12M |
|
|
OBSV
18
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $6.42M | 1.14% | +424,300 | New | +$6.42M |
|
|
BHVN
19
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.32M | 1.13% | +160,000 | New | +$6.32M |
|
|
ZGNX
20
DELISTED
Zogenix, Inc.
ZGNX
| $4.88M | 0.87% | +110,500 | New | +$4.88M |
|
21
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $4.83M | 0.86% | +345,000 | New | +$4.83M |
|
|
CUTR
22
DELISTED
Cutera, Inc.
CUTR
| $4.23M | 0.75% | 105,000 +35,000 | +50% | +$1.41M |
|
23
Xenon Pharmaceuticals
XENE
$2.98B
| $4.14M | 0.74% | +450,000 | New | +$4.14M |
|
24
Apellis Pharmaceuticals
APLS
$3.48B
| $3.7M | 0.66% | +168,000 | New | +$3.7M |
|
25
MEI Pharma
MEIP
$160M
| $3.47M | 0.62% | +880,087 | New | +$3.47M |
|